New Therapeutic Effects of Anthocyanins: Antiobesity Effect, Antidiabetes Effect, and Vision Improvement

Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions

Volumn , Issue , 2009, Pages 273-290

  Tsuda, Takanori ^a   Matsumoto, Hitoshi ^b  

^a CHUBU UNIVERSITY   (Japan)

^b MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

"metabolic syndrome" characterized by group of metabolic risk factors; Adipocyte dysfunction role in metabolic syndrome development; Anrhocyanins and type 2 diabetes; Anthocyanins regulating adipocyte functions including adiopocytokine expression; Antiobesity effect of anthocyanins; Ciliary muscle relaxation mechanism by anthocyanin; Inhibitory effect of d3r and pharmacological analyses; New therapeutic effects of anthocyanins antiobesity effect, antidiabetes effect, and vision improvement; Vision improvement transient refractive alteration study

Indexed keywords

EID: 80052456404     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813807263.ch18     Document Type: Chapter

References (62)

1. Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, and Juhan-Vague I. 2000. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 49:1374-1380.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257:79-83.
3. Brouillard R. 1988. Flavonoids and flower color. In: Harborne JB (Ed), The Flavonoids, Chapman and Hall, London, pp 525-538.
4. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, and Park KS. 2006. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 29:2457-2461.
5. Craig RL, Chu WS, and Elbein SC. 2006. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab. 90:338-344.
6. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, and Arner P. 1998. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 41:65-71.
7. Fried SK, Burkin DA, and Greenberg AS. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 83:847-850.
8. Friedman JM and Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature. 395:763-770.
9. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, and Lodish HF. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 98:2005-2010.
10. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, and McNurlan MA. 2007. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in non-obese subjects without type 2 diabetes. J Clin Endocrinol Metab. 92:1886-1890.
11. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, and Kahn BB. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 354:2552-2563.
12. Grandjean E and Vigliani E (Ed). 1980. Ergonomic Aspect of VDTs, Taylor and Francis Co, London.
13. Hotamisligil GS, Shargill NS, and Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-a: Direct role in obesity-linked insulin resistance. Science. 259:87-91.
14. Iida H, Mastsumoto H, Morifuji M, Nakajima N, Kinoshita S. 2008. Effect of blackcurrent anthocyanin intake on refractive and accommodative alteration by fatigue load of staying awake for 24 hours. J. Eye. 25:114-118.
15. Iwai K, Kim MY, Onodera A, and Matsue H. 2006. Alpha-glucosidase inhibitory and antihyperglycemic effects of polyphenols in the fruit of Viburnum dilatatum Thunb. J Agric Food Chem. 54:4588-4592.
16. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, and Shimomura I. 2003. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes. 52:1655-1663.
17. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM, and Jordan J. 2006. Retinol-binding protein 4 in human obesity. Diabetes. 55:2805-2810.
18. Japan Psychotechnology Institute. 1990. Uchida-Kraepelin Psychological Test Data Book. Kaneko-shobo, Tokyo, pp 104-121.
19. Kahn BB and Jeffrey S. 2000. Flier obesity and insulin resistance. J Clin Invest. 106:473-481.
20. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, and Kadowaki T. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 281:26602-26614.
21. Kamikawatoko S, Tokoro T, Azuma H, Hamasaki H, and Ishida A. 1995. The effects of endothelin-1 on isolated bovine ciliary muscle. Exp Eye Res. 61:559-564.
22. Kamikawatoko S, Tokoro T, Ishida A, Masuda H, Hamasaki H, Sato J, and Azuma H. 1998. Nitric oxide relaxes bovine ciliary muscle contracted by carbachol through elevation of cyclic GMP. Exp Eye Res. 66(1):1-7.
23. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, and Kasuga M. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 116: 1494-1505.
24. Kirshner B and Guyatt GH. 1985. A methodological framework for assessing health indices. J Chron Dis. 38:27-36.
25. Lau KS, Grange RW, Chang WJ, Kamm KE, Sarelius I, and Stull JT. 1998. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett. 431:71-74.
26. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, and Matsubara K. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem Biophys Res Commun. 221:16286-16289.
27. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, and Matsuzawa Y. 2001. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50:2094-2099.
28. Matsui T, Ueda T, Oki T, Sugita K, Terahara N, and Matsumoto K. 2001. alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. alpha-Glucosidase inhibition by isolated acylated anthocyanins. J Agric Food Chem. 49:1952-1956.
29. Matsumoto H, Hanamura S, Kawakami T, Sato Y, Hirayama M. 2001a. A Preparative-scale isolation of four anthocyanin components in blackcurrant (Ribes nigrum L.) fruits. J Agric Food Chem. 49(3): 1541-1545.
30. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M, and Tsuda T. 2001b. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem. 49(3):1546-1551.
31. Matsumoto H, Kamm KE, Stull JT, and Azuma H. 2005. Delphinidin-3-rutinoside relaxes the bovine ciliary smooth muscle through activation of ET(B) receptor and NO/cGMP pathway. Exp Eye Res. 80(3):313-322.
32. Matsumoto H, Nakamura Y, Hirayama M, Tachibanaki S, and Kawamura S. 2003. The stimulatory effect of cyanidin glycosides on the regeneration of rhodopsin. J Agric Food Chem. 51(12):3560-3563.
33. Matsumoto H, Nakamura Y, Iida H, Ito K, and Ohguro H. 2006. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp Eye Res. 83(2):348-56.
34. Matsuzawa Y. 2005. Adipocytokines and metabolic syndrome. Semin Vasc Med. 5:34-39.
35. Morazzoni P and Bombardelli E. 1996. Vaccinium myrtillus L. Fitoterapia. 67:3-29.
36. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, Kumada M, Erdenebulgan B, Zolzaya K, Lkhagvasuren T, and Iwamoto S. 2007. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet. 120:879-888.
37. Murata K, Araki S, and Yokoyama K. 1996. Accumulation of VDT work-related visual fatigue assessed by visual evoked potential, near point distance and critical flicker fusion. Ind Health. 34:61-69.
38. Nakaishi H, Matsumoto H, Tominaga S, and Hirayama M. 2000. Effects of blackcurrant anthocyanosides intake on dark adaptation and VDT work-induced transient refractive alternation in healthy humans. Altern Med Rev. 5(6):553-562.
39. Neuringer M. 2000. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: Methods, results, and implications. Am J Clin Nutr. 71:256S-267S.
40. Pickup JC, Chusney GD, Thomas SM, and Burt D. 2002. Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 67:291-300.
41. Pradhan AD, Manson JE, Rifai N, Buring JE, and Ridker PM. 2001. C-reactive protein, interleukin 6, and risk of developing type2 diabetes mellitus. JAMA. 286:327-334.
42. Sartipy P and Loskutoff DJ. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 100:7265-7270.
43. Sasaki R, Nishimura N, Hoshino H, Isa Y, Kadowaki M, Ichi T, Tanaka A, Nishiumi S, Fukuda I, Ashida H, Horio F, and Tsuda T. 2007. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol. 74:1619-1627.
44. Snodderly DM. 1995. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 62:1448S-1461S.
45. Takashima N, Tomoike H, and Iwai N. 2006. Retinol-binding protein 4 and insulin resistance. N Engl J Med. 355:1392.
46. Tokoro T. 1998. Development mechanism of low myopia and therapeutic possibilities. Nippon Ganka Gakkai Zasshi. 102:796-812.
47. Tsuda T. 2008. Regulation of adipocyte function by anthocyanins: Possibility of preventing the metabolic syndrome. J Agric Food Chem. 56:642-646.
48. Tsuda T, Horio F, Kato Y, Osawa T. 2002a. Cyanidin 3-O-ß-D-glucoside attenuates the hepatic ischemia-reperfusion injury through a decrease in the neutrophil chemoattractant production in rats. J Nutr Sci Vitaminol. 48:134-141.
49. Tsuda T, Horio F, Kitoh J, and Osawa T. 1999. Protective effects of dietary cyanidin 3-O-ß-D-glucoside on ischemia-reperfusion injury in rats. Arch Biochem Biophys. 368:361-366.
50. Tsuda T, Horio F, and Osawa T. 1998. Dietary cyanidin 3-O-ß-D-glucoside increases ex vivo oxidation resistance of serum in rats. Lipids. 33:583-588.
51. Tsuda T, Horio F, Osawa T. 2002b. Cyanidin 3-O-ß-D-glucoside suppresses nitric oxide production during a zymosan treatment in rats. J Nutr Sci Vitaminol. 48:305-310.
52. Tsuda T, Horio F, Uchida K, Aoki H, and Osawa T. 2003. Dietary cyanidin 3-O-yß-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr. 133:2125-2130.
53. Tsuda T, Ueno Y, Aoki H, Koda T, Horio F, Takahashi N, Kawada T, and Osawa T. 2004. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commn. 316:149-157.
54. Tsuda T, Ueno Y, Yoshikawa T, Kojo H, and Osawa T. 2006. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol. 71:1184-1197.
55. Tyrrell RA and Leibowitz HZ. 1990. The relation of vergence effort to reports on visual fatigue following prolonged near work. Hum Factors. 32:341-357.
56. Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, and Maru Y. 2004. Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J Biol Chem. 279:4075-4083.
57. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and FerranteAW, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112:1796-1808.
58. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, and Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity related insulin resistance. J Clin Invest. 112:1821-1830.
59. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Ohara MI, Nagamatsu S, and Ishida H. 2005. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endcrinol Metab. 289:E643-E649.
60. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, and Kadowaki T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7:941-946.
61. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, and Kahn BB. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 436:356-362.
62. Zirlik A, Leugers A, Lohrmann J, Ernst S, Sobel BE, Bode C, and Nordt TK. 2004. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones. Thromb Haemost. 70:138-143.